Here’s a slide presentation from the Text4Baby team that they presented yesterday. This has been one of the biggest SMS programs in the country and has gotten a lot of press. They did a survey of people about their plans to get flu shots and also share some other data and plans.
Slideshare: 2012 Digital Trends For Healthcare Marketing
Good deck that I found on Slideshare.net.
What’s A PAM Score?
PAMTM is the Patient Activation Measure which was developed by Dr. Hibbard, Dr. Bill Mahoney, and colleagues. It helps you gauge how much people feel in charge of their healthcare. To find out more, you can go to InsigniaHealth’s website.
Given the focus on health engagement across the industry these days, I think this is an important tool to consider. It’s been used broadly and has been validated in a lot of published studies. The questions lead people to be assigned to one of four different activation levels.

You can collect and use the PAM score for segmentation, developing customized messaging, measuring program success, and/or identifying at risk populations.
A few other interesting points from one of their FAQ documents were:
- Patients who are more activated are more likely to adopt positive behaviors regardless of plan design.
- People with higher activation levels are more likely to choose consumer directed plans.
- People with low activation often feel overwhelmed with the task of taking care of themselves.
- You increase the level of success in by breaking down change into smaller steps where the consumer has a greater likelihood of success.
Which PBMs Have The Highest Mail Order Penetration?
I was looking at some data from earlier this year (Q1 – 2011) from the AIS quarterly survey of PBMs. I thought this was a nice summary of mail order penetration by PBM. As you can see, it identifies some areas of opportunity:
- Will Express Scripts’ mail penetration go up with the potential acquisition of Medco? Or, will Medco’s go down?
- Will anyone be able to match the Medco mail penetration?
- Will Aetna’s mail penetration go up to the CVS Caremark penetration rate?
- How will Prime Therapeutics, SXC, and CatalystRx increase their mail penetration?
Overall, the mail penetration of the industry has dropped to 16.3% which is the lowest it’s been since 2004 when it was 12.9% (according to AIS). [Note: These are based on adjusted Rxs.]

Will Pfizer Strategy On Lipitor Become The Norm?
Remember Twisted Sister’s song – We’re Not Going To Take It Anymore?
That’ seems like a good summary of the Pfizer response to the typical market dynamics around patent expiration.
Here’s a summary of what they’re doing:
- Pfizer is striking deals with PBMs to offer them brand Lipitor at a lower cost (net of rebate) than the generic drugs which are coming to market during the exclusivity period.
- Pfizer is continuing to offer their $4 coupon for brand Lipitor direct-to-consumers.
- Pfizer is continuing to advertise Lipitor and talking about “if Lipitor has been working for you, stay with it”.
- Pfizer is partnering with Diplomat Pharmacy to sell Lipitor directly to the consumer through mail order.
- Pfizer is offering pharmacies additional services around adherence for helping keep patients on Lipitor.
Here’s some key questions on implications:
- If I’m the authorized generic, how do I feel? I thought I had a deal by which I was bringing a drug to market and making some money during the exclusivity period. Will this change the way that authorized generic deals get structured?
- If I’m the generic manufacturer that has the 180-day exclusivity, how do I feel? I’ve just lost a lot of my opportunity. Will this change the economics of generic manufacturers? I believe most of their profit is made during the exclusivity period.
- Will other brand manufacturers follow suit on other patent expirations?
- Will the PBM response to couponing intensify with their push into couponing when there is a multi-source generic available?
- Will this serve as a bridge until they can get OTC Lipitor approved? And, will that ever happen?
- How does this affect retailers who make more money on the generics and won’t see the increased rebate dollars?
- For PBM clients that get rebate dollars shared with them, these deals with Pfizer are probably a win (i.e., lower cost). What about those clients that don’t? How are they being made whole? What about clients of clients (i.e., employers who contract with a TPA or MCO who gets the rebates but doesn’t share them)?
- How hard does it become to transition patients off Lipitor when Pfizer stops offering the increased rebates or lower cost?
This could be a game changing moment in the industry. We’ve seen lots of shifts, and I would add this as a new phase in the industry.
- 1.0 = Traditional focus on MDs and heavy use of people to detail physicians.
- 2.0 = Shift to DTC advertising still supported with detail reps.
- 3.0 = Increased power of PBMs and focus on rebating and formulary positioning.
- 4.0 = Rise of generics and shift to specialty.
- 5.0 = DTC couponing and broader disease centric strategies.
- 6.0 = New business models??
Canadian Pharmacy Loyalty Program
Lawtons Drugs in Canada is partnering with LoyaltyOne to offer an air miles program tied to participation in an informational program on healthy behaviors.
A few of the interesting statistics:
- 69% were interested in receiving awards for incorporating healthy advice from their pharmacists into their self-management
- 58% were more likely to pick a pharmacy if it offered rewards
- 36% said they would be more likely to take care of themselves if they got rewarded
The Dynamic Video Book: Aetna Example (Specialty Opportunity)

About a year ago, I picked up a “book” at an Aetna booth at a conference. I’d shown the technology to a few clients, but I’d never had a physical example. I thought I would share it here. When you open it up, it has a video embedded into the book. The video has several different options for messaging that you can view by pressing the buttons.

The cool aspect of the book is that it can be linked up to a computer so the videos can be updated over time. It’s produced by a company called Americhip who calls it “Video in Print”.
I’m sure it’s more expensive than a typical direct mail piece, but it can be used and updated over time. My thought is that this is a great tool for specialty pharmacy. These are high cost patients. Imagine a book with the following videos that came with their first script:
- Understanding your disease
- What to expect from your medicine
- How to access support
- Refilling your medication
- The importance of adherence
The content of these videos could change over time as their condition evolves, as they change medications, or even based on different lab values.
Reprint: Getting Aligned For Consumer Engagement
(This just appeared in the publication by Frost & Sullivan and McKesson called “Mastering the Art and Science of Patient Adherence“. It was written by me so I’m sharing it here also for those of you that don’t get that publication.)
According to the 15th Annual NBGH/Towers Watson Health Survey, employees’ poor health habits are the number one issue for maintaining affordable benefits. Since studies have shown that 50-to-70 percent of healthcare costs are attributed to consumer choices and adherence is one of those issues, the topic of how to engage consumers isn’t going away.
The challenge is getting the healthcare industry to use analytics and technology tools when engaging the consumer in a way that works for each individual and builds on their proven success in other industries. Healthcare has an enormous amount of consumer data ranging from demographics to claims and behavior data. Consequently, there is great opportunity to use this data to engage consumers in their health to improve clinical outcomes. While on the one hand, it’s like motivating consumers to buy a good, the reality is that healthcare is both personal and local which complicates the standard segmentation models.
This is a dynamic time where people are experimenting with different strategies for engagement. For instance, in medication adherence, people are trying everything from teaming those who have chronic conditions with community pharmacists to make sure they are taking their medications correctly to technology that monitors when the pill actually enters your body. But, there are still fundamental gaps in the process which can be addressed using interactive technology to complement the pharmacist interventions.
Consumer engagement in healthcare is increasingly moving to new channels with 59 percent of adults in the U.S. looking for health information online and 9 percent using mobile health applications according to Pew Research Center. Additionally, there is more and more participation in social media or peer-to-peer healthcare applications. Modes like SMS, which companies are starting to leverage in programs like Text4Baby or the diabetes reminder program recently launched by Aetna, are gaining popularity. Companies like Walgreens have also begun exploring the use of SMS and Quick Response (QR) codes for medication refills.
At the end of the day, consumers want preference-based marketing where they can elect how to best engage them, but that doesn’t mean that’s the most likely channel to get them to take action.They want you to learn from their past responses to improve your future outreach, but they are also skeptic about how their data is used. You have to put yourself in their shoes to create the optimal consumer experience. You have to deliver the right message to the right consumer at the right time using the right sequence and combination of channels.This is not easy.
So, if you’re going to optimize your resources and build the best consumer experience, you need an approach which is dynamic and personalizes each experience. For example, we found that creating the right sequence and timing around direct mail and automated calls improved results by as much as 100 percent in a pharmacy program. Or, in another case, at Silverlink Communications, we found that using a male voice in an automated call to Latinos got an 89 percent better engagement rate around colonoscopies. We also know that using a peer pressure message does not work in motivating seniors to take action in both a retail-to-mail program and a cancer screening program, but does work for those younger than 55-years-old?
You have to make simple messaging relevant to them—why should I get a vaccination, why is medication adherence important, how can you address my barriers? Only an ongoing test and learn approach to consumer insights will suffice, and those that figure this out will become critical in the ongoing fight for mindshare and trust. But, this isn’t a stand-alone opportunity. We have to partner with providers to improve engagement, adherence, and ultimately outcomes in different forms. We have to offer them a platform for engagement that is built upon consumer insights and provides a unique consumer experience to them based on their disease, their demographic attributes, and their plan design. All of these factor into their behavior and are important in “nudging” them towards healthcare engagement and ultimately, better health.
“Code Lavender” – Focusing On The Patient Experience
If you don’t know it yet, the consumer “experience” is rapidly becoming the hot topic. I’ve talked about it a lot beginning with companies like Cigna that have hired and staffed a consumer experience team and Chief Experience Officer. But, as the WSJ pointed out earlier this week in their article “A Financial Incentive For A Better Bedside Manner“, this is getting quantified in the provider world. One might argue that experience has always mattered more in the provider world since it’s easier to switch hospitals or physicians than insurance companies, but that is likely to continue to change as the individual insurance world and Medicare continue to create competition for the individual.
For payers, you can already see this individual market playing out with the growth of retail stores which is where the experience begins. In other cases, the PBMs and payers have to rely on many cases on their call centers as the front-end of the consumer experience. Additionally, with pharmacy being the most used benefit, this is another critical area. And, we know that pharmacy satisfaction is highly correlated with overall payer satisfaction.
But, let me pull a few things that caught my attention in the WSJ article:
CMS will begin withholding 1% of their payments and tying payment to quality standards for medical care AND patient satisfaction surveys known as HCAHPS (Hospital Consumer Assessment of Healthcare Providers and Services). This will go up to 2% in 2017.
The survey is a 27-question survey sent to a random sample of discharged patients (about 25% of the 36M patients admitted in 2010 with a pretty low response rate of 7%). It asks about cleanliness, quiet, communications, and an overall satisfaction based on something similar to the Net Promoter Score (i.e., would you recommend the hospital to friends and family).
67% of patients give their hospitals the top two ratings on a scale of 1-10 (which I actually think is pretty good).
Only 60% say that doctors and nurses always communicated well about medications (which was higher than I expected).
Cleveland Clinic Chief Executive Delos “Toby” Cosgrove, a heart surgeon by training, says he had an epiphany several years ago at a Harvard Business School seminar, where a young woman raised her hand and told him that despite the clinic’s stellar medical reputation, her grandfather had chosen to go elsewhere for surgery because “we heard you don’t have empathy.”
-
The Cleveland Clinic calls their program HEART—for hear the concern, empathize, apologize, respond and thank. They also use the term “Code Lavender” for patients or family members who need immediate comfort.
I look forward to watching how this transforms over time. I know I’ve seen this play out in the dentist’s offices for my kids. The waiting rooms have video games and other things to keep them and their siblings busy, but I do agree with the article that this may unfairly bias the wealthier hospitals.
Sustained Patient Engagement Around Hypertension: Silverlink and Aetna
At Silverlink, we had a great opportunity to work with one of our clients and publicize it. This morning, Aetna released a joint press release with us about our hypertension program.
As companies continue to look at new ways to use technology to engage patients around chronic diseases, solutions like this offer companies a unique way to blend multiple channels into an overall consumer experience that improves engagement and outcomes.
From the press release:
The program also achieved high levels of engagement, with nearly 60 percent of participants continuing to actively monitor their blood pressure by using a free blood pressure monitor and submitting readings on a monthly basis. The frequency of participants’ cholesterol (low-density lipoprotein (LDL) cholesterol) screening also improved 5 percent.
“By helping our Medicare members manage their high blood pressure, we are hoping to help prevent heart disease, strokes and even deaths,” says Randall Krakauer, MD, FACP, FACR, Aetna’s national Medicare medical director. “Our nurse case managers work closely with our members and do a tremendous job providing them with the information, tools and support they need to help them control and improve various chronic conditions, including hypertension. The results of our program with Silverlink demonstrate that an automated program can further support and engage members in managing their own health conditions.”
Retail Pharmacy Mobile Applications
I’ve talked before about some of the mobile PBM efforts, but what about the retail pharmacies. You should expect that the chains will have different mobile strategies than the grocery stores or the big box retailers. And, it will be interesting to see how the independents might collaborate on a shared platform.
Here’s a few things already out there:
- Walmart new shopping application and Walmart’s page on mobile
- CVS retail application
- Walgreens has a mobile pharmacy app
- Target also has a mobile pharmacy application
So what should or could pharmacies offer consumers in terms of mobile applications:
- A refill application is a minimum
- Education or drug information is another basic
- There are certainly some geographic options such as a store locator or clinic locator
- There are options for location based check-in using Foursquare
- Scheduling MTM consultations or vaccinations are a reasonable option
- What about promoting saving thru 90-day retail or generics?
- As retail pharmacies are in the specialty business, there could be opportunities to promote this channel and offer support.
- Telemonitoring is another option (e.g., FaceTime)
- Use of QR code is another part as is augmenting the shopping experience with augmented reality
- Of course, couponing will be part of the solution, but what I’d like is someone who would download my shopping receipts (from multiple companies) and provide me with relevant savings.
- Should it include Rx coupons? Unlike the PBMs, retailers want traffic and if coupons increase adherence then why not.
- There are other options like photos and integration with social networks and tools.
I think one of the key “killer apps” is secure rules based messaging. Imagine using data to identify when you need a vaccination or identifying a potential drug-food issue or having age based triggers. These could be sent directly to the consumer in a secure environment. Of course, we’re only at about 10% adoption and the key question is whether these are the key consumer that everyone wants to attract. Are they the high utilizers? Do they buy other goods?
More to come here. This is a rapidly evolving space.
The Augmented Reality Prescription Bottle
I was watching a YouTube video on Starbucks’ augmented reality cup which got me thinking. Why not do the same with the prescription bottle?
What a great way to engage the tech savvy consumer.
Perhaps you could provide a plain language summary of information about the medication. You could give a list of side effects. Or show how to take the medication.
Perhaps it could have an embedded survey that you complete weekly.
And, it seems like an easy opportunity for someone to offer an augmented reality applications for all medications. Hold up the phone to a pill and get information on it. (maybe a little harder)
I think there is a lot more here as companies like Lamar continue to evolve.
Highlights From the Takeda / PBMI 2011-2012 Prescription Drug Report
PBMI puts this out each year with funding support from Takeda. It is another one of those great annual reports full of lots of trend data for you to digest. Let me pull out a few of the things that stood out to me, but I recommend you read the entire thing yourself:
- Use of 4-tier plans grew by 25% in 2011.
- Specialty copays increased by 37% (to $84).
- Plans continue to offer 90-day mail at a lower copay multiple than 90-day retail.
- Nearly 60% of plans allow 90-day retail prescriptions. [Wow! This was a shocker to me.]
- 30% of respondents require specialty medications to be filled by their PBM. [Which seemed low to me.]
- Only 5% of respondents said they give their PBM responsibility for plan design.
- 18% of plans have mandatory mail (although the statistic is 26% for respondents who have pharmacy provided as a carve-out).
- 21% of plans have a limited retail network.
- 36% of plans have copay waivers.
- 7% of plans cover some form of genetic testing.
- In general, there was an equal view of all the forces impacting benefit plans.
- 64% of plans are focusing on member education to help them control costs. [exactly what we do at Silverlink everyday!]
Here’s a key chart on average copays for 3-tier plan designs.
Another summary they show from some external research is below:
Adam Fein recently pointed this out, but the use of MAC pricing at mail is pitifully low at 18% versus 42% for 30-day retail. (More from Adam on the report.)
I’m always interested in the overall use of programs by plans which is summarized here. Interestingly, there were three areas which carve-in did much less than carve-out – outbound phone calls, retro DUR, and therapeutic substitution.
They also include a summary of several research studies on adherence with a quote from me:
“In working with healthcare companies around adherence, our focus is always on how to best use data and technology to personalize interventions in a scalable way,” said George Van Antwerp, 2011-2012 Prescription Drug Benefit Cost and Plan Design Report Advisory Board member. “Medication adherence is a multi-faceted issue. While there is no silver bullet, technology can help deliver different messages to consumers based on the complexity of their condition, specific medications, and their plan design (for example). But, while technology can provide the initial nudge, the care team has to work together to address health literacy and build an understanding of the condition, the medication, and value of adherence.”
Another data point that I often use from here is the average number of Rxs PMPM:
One Challenge Of Medicare OEP – Satisfaction
We’re in the Medicare open enrollment period right now. This is a highly competitive time for MA and PDP plans to compete for new members and to get members to switch to their plans. I’ve talked about the Star Ratings process before. I’ve talked a little about the limited network offerings before.
This time, I wanted to focus on a recent study by Medicare Today that was put out on satisfaction. It shows:
- 95% say their current Part D plan works well, with 94% saying it is easy to use.
- 82% say their Part D plan offers good value.
- 67% say they have lowered their prescription drug spending.
- 34% say they used to skip or reduce their prescription medicine doses to save money, but now no longer have to do so.
- Two of every three seniors said they are unlikely to shop around.
Did You Know PhRMA Has A YouTube Channel?
I just ran across this, and I figured I would share it. PhRMA is the Pharmaceuticals Research and Manufacturers of America. They represent they pharma and biotech companies.
Here’s a few of the videos from the site. One on Part D and one on adherence.
My Eight PBM Predictions For 2012
I recently heard one of the key CEOs in the PBM industry say that his crystal ball for 2012 was fuzzy, and he wasn’t sure what was going to happen. (Not particularly reassuring.) That being said…it’s an exciting time, and I’m going to take my pass at predictions anyways.
- The proposed Express Scripts acquisition of Medco will take place although they will be required to sell off some specialty assets. This will create a new specialty player and will also trigger further consolidation and acquisitions. You will also see many of the Medco people go to new healthcare companies throughout the industry to drive change.
- The contract dispute between Express Scripts and Walgreens will get resolved shortly after 1/1/12, but it will serve as the trigger for limited networks as multiple clients will keep Walgreens out of the network since they’ve addressed most of the disruption and achieved savings. But, you will also see several companies quickly add Walgreens back into their network.
- Star Ratings will trigger a bigger focus on adherence across the industry and begin to create outcomes-based performance measures that the commercial business starts to see in their PBM contracts linking payment to performance.
- Lipitor will be a disruptive item throughout the year with aggressive Pfizer rebating, the overhang from it potentially going OTC, and the pricing of the initial generic.
- Innovation will finally begin to shift to the specialty space with this being the primary area of concern from a trend management and clinical perspective. Clients will expect innovative ways of engaging patients and improving outcomes which will push closer links between pharma and PBMs around key drugs and complex conditions. The focus on specialty spend in medical will continue, but the increasing percentage of infusion drugs will challenge this and push specialty to look for more ways of engaging with the physician.
- The “retailing of healthcare” through storefronts will manifest itself in different ways in pharmacy with greater focus on specialty at retail, pharmacists as part of the ACO/PCMH concept, MTM, and ultimately through exchange based partnerships with large payers.
- Integration of medical, pharmacy, and lab data will be a huge focus on PBMs create targeting algorithms and databases for segmentation, targeting, and ultimately engaging consumers around specific health behaviors.
- Telemedicine in the form of telemonitoring will link into the retail pharmacy clinic strategy as they extend their pharmacy relationship from an event based relationship to an ongoing monitoring relationship around key conditions like diabetes.
Two things that I expect to continue to be areas of focus will be the development and execution of a mobile strategy and continued exploration in the area of personalized medicine and genomics.
The one outlier which I’m not sure of yet is Medicaid pharmacy. It’s been a hot topic lately, but I’m still unsure of whether that will radically change in 2012 or not.
[Interested in sharing your opinions on 2012 in a formal way? I'm going to reach out to several companies and ask their thought leaders or executives to do an "interview" with me about their predictions for 2012. Let me know if you'd like to participate.]
[And, don't forget that you can sign up to have these posts e-mailed to you whenever I write them by signing up for my e-mail list on the right side of the blog. Thanks for reading.]
Tiny Tower Retail Pharmacy Missed Branding Opportunity
Tiny Tower is a simple yet addictive game you can play on your iPhone or iPad. My kids figured out the other day that you could re-name the floors. For example, one of the floors is a pharmacy.

So, instead of saying “pharmacy” this could say Walgreens or CVS or Express Scripts. What a missed opportunity. I’ve talked about this before, but I think the pharmacy industry in general has missed integrating themselves into Hollywood and gaming. When’s the last movie or TV show you saw where the primary actor was a pharmacist or worked at a PBM or even worked at a health insurance company (and was shown in a positive light)?
Here’s an easy branding opportunity. It also seems like an easy revenue source for the Tiny Tower founders. Why not have companies pay them to brand these? Why not have people playing the game earn points to buy up from McDonalds to Red Robin?
Three Pillars of Adherence (NEHI)
I was digging through some adherence materials, and I stopped on the NEHI graphic from their report “Thinking Outside The Pillbox” which first quantified the impact of non-adherence at $290B (a number which everyone uses now).
I don’t remember every posting it on the blog so I’m sharing it now. I think it hits on the key topics that we all talk about:
- We have to get it right from the beginning with the drug regiment.
- Cost can be an issue so if possible address it.
- But, the biggest issues are with understanding (literacy), side effects, creating a habit, and many other things that require education and ongoing intervention and support for the patient.
[Note: NEHI has now releasesdd their roadmap on Medication Adherence which I'll review in a subsequent post.]
Why Don’t Physicians Use More Information Therapy
My PCP is very good about giving me information to read every time I visit him. (Never mind that it sits in a pile on my desk.) But, I believe this is under-utilized in today’s information rich society.
I was reading an article this morning from PharmaVOICE about physicians not using certain medications or treatments because they didn’t have the time to spend with patients explaining them. Therefore, they default to the “easier” solution which requires less explaining. Is this prevalent? I don’t know.
The article talked about a survey from Sermo and Aetna Health which revealed that almost 2/3rds of the 1,000 MDs surveyed felt that “the current health care environment is detrimental to the delivery of care”. And, less than 1/5th felt that “they could make clinical decisions based on the what was best for the patient, rather than on what the payers are willing to cover”. Pretty scary and sad.
Imagine if the physician was using an electronic interface during the encounter. They could pre-create several information packets around certain diseases, drugs, and/or treatments. When the patient was diagnosed and a treatment plan agreed to, they could e-mail the package to the patient. It might include written information, links to websites, YouTube videos, or other assets. I would imagine this could be very powerful and address the common gaps that exist between what the physician says and the patient hears.
[The article was "Is the Business of Health Care Getting in the Way of Providing Good Health Care? by Ken Ribotsky in PharmaVOICE from October 2011.]
What Does A PBM Do (Video)?
A big question is always “what is a PBM“. PCMA has developed a new video which shows some of the things that a PBM does. Here it is…
Predicting Medication Adherence
Is there a secret sauce? (Hint: past behavior)
It always important to be skeptical, but there are certainly attributes like the number of Rxs, gender, condition, copay amount, and other factors that contribute to the likelihood of a consumer being adherent.
But, one of the big discussions is around how to use other variables. FICO, the company that creates credit scores, has created an adherence score. In today’s WSJ, they shared this image about predicting adherence. Interesting…
Why Not Make “Low Fat” Normal And Label Others “Full Fat”
One of the foods my kid loves comes in both normal and a low-fat version. But, we’ve always bought the low-fat version. One day, they were out so I bought the normal version. I was surprised when he was upset. Why did you buy me the full fat version he asked?
It got me thinking. Like “loss aversion” would reversing the positioning of products work? There’s always talk about the “fat tax“. Why not try making low-fat the standard and requiring labeling that points out what products are full of fat?
Should Health Companies Be Brutally Honest With Consumers?
I saw a statistic today that said that the Domino Pizza’s stock price has gone up by 233% since they began acknowledging that they had a reputation of a low-quality product. Fascinating!
Would that work for health plans or PBMs or pharmaceutical manufacturers? If they acknowledged the perception that consumers have for them, would that engage consumers? Would consumers respond well to that?
Imagine messaging around prior authorization that sounded more like this…
“We’re calling to let you know that you need a prior authorization to get your [drug, service, device]. I know you think we’re just doing this to cut costs and override your physician’s decisions, but that’s not true. We care deeply about you, but our physician team determined that there’s a chance for overuse of this [drug, service, device]. All we’re asking is for your physician to answer a few questions to validate the proper use. We’ve even launched a web service so this can be done with minimal disruption.”
Lots Of Consumers Looking For Generic Lipitor
Assuming my blog volume is any indicator, it seems like consumers are increasingly looking for information on generic Lipitor. My blog volume doubled last week.
If you type “Lipitor going generic” into Google, I’m the first page returned (after paid search). [I always love finding these Search Engine Optimization (SEO) results.]
Will The Stars Align To Drive Adherence?
We all know that adherence to prescriptions is a problem. People don’t start on their medications. People don’t stay on their medications. But, another problem also exists which is finding the ROI on adherence. While the ROI is clear to the manufacturer or even to the pharmacy, it’s often less clear to the payer.
This is not true in every category. Diabetes and several other conditions have been shown to have an ROI associated with intervention programs that improve adherence. But what about all the others.
In the short-term, I expect you’ll see the CMS Star Ratings and bonus payments drive behavior in three critical categories that are now measured in the 2012 for MAPD and PDP plans. (see technical notes on 2012 measures)
If you’re not familiar with the Star Ratings system, you should read this. In 2012, there were three new adherence measures added. Not only are they now part of the evaluation process, but they were weighted more heavily than some of the operational measures. A good indication of focus on quality of care.
Getting more Stars is important since it is linked to bonus dollars that the plans can get. And, there aren’t many Five Star Plans. Only 9 plans received 5-Star Ratings for 2012 (see article). [Interestingly, I think one of the unique assets that Express Scripts is buying in the proposed Medco acquisition is one of the 4 Five-Star PDP plans.]
“The Medicare star quality rating system encourages health plans to improve care and service, leading to better patient experiences across the board,” Jed Weissberg, a senior vice president at Kaiser Permanente. (from 5-star article above)
The adherence measures focus on diabetes, high cholesterol, and hypertension and use Proportion of Days Covered (PDC) rather than MPR for their measurement. Certainly, one of the things we’re seeing at Silverlink with our Star Power program is that many of these Star Measures can be influenced by communications. Adherence is certainly one of those big areas of opportunity for plans to focus on.
While the benefit is obvious to the plan in terms of reimbursement, the big question is whether consumers care about Star Ratings or just focus on lowest price point and access to pharmacies or specific medications. A Kaiser study that was done seems to indicate that the answer is no.
Conducted by Harris Interactive, the survey showed that only 18 percent of Medicare-eligible seniors said that they are familiar with the government’s rating system. Of those that are familiar, less than one-third have used the system to select their health plan. Moreover, only 2 percent of respondents were aware of how their current plans rates.
Since we’re in open enrollment for Medicare right now (see Medicare.gov to evaluate options), perhaps we’ll get some data in early 2012. 2012 will also be the first year for the 5-Star plans to be able to market all year round and not be limited to the OEP (open enrollment period).
But, one of the things I found interesting as I looked on the Medicare.gov site to “select” a plan in my area is that there is an option to “Select Plan Ratings” but even I wasn’t sure what that was. It’s not intuitive to the consumer that this is a quality rating for them to pay attention to. And, it appears that the default order of options which is presented to you is based on price.
Infographic: Word Of Mouth Advertising
As healthcare moves toward a more retail model, word of mouth advertising becomes more important. This is already true in terms of physician’s influence on prescription use or in some cases distribution location. It’s also important from a Medicare perspective. But, this will continue to increase in importance in the future with health reform.
I also believe that clients will require satisfaction scores as part of their SLAs (service level agreements) in many cases in the future and/or tie bonus dollars to this. Will you be prepared? Do you understand your customers’ satisfaction with you? Do you know how to impact it?
Managing Stress As One Of 65M Caregivers
65 million Americans are caregivers which can be a stressful job. I think more and more companies that I consult with are looking at how to engage the caregivers as part of the overall health team. With that in mind, I thought I would share this quote. Managing stress as a caregiver is important so you don’t burn out.
“When you have a bad job in a toxic workplace, you feel trapped, but you can always try to find another job,” said Sharon Brothers, a veteran social worker who is now executive vice president of Caregiver Village (www.caregivervillage.com), an omnibus Internet community and resource hub for caregivers that includes expert forum hosts and even an online caregiver game. “Caregivers, however, can’t just find another role. They are caring for a loved one, so the stress they live with is real and the boss they report to is themselves. They feel trapped by their love and obligation to their family members, which makes it exponentially more difficult for them to get a break, because they feel guilty whenever they try to take one. In fact, studies show that being a family caregiver is one of the most stressful ‘occupations’ in the country today.”
Communications: Get To The Point
I got to catch up with one of my first bosses tonight. He taught me a lot about strategy, consulting, and people.
One of the lessons I never forgot was about communicating. I don’t always do it, but he used to tell me two things:
- If you’re going to leave me a voicemail, tell me the key points in the first 30 seconds.
- If you send me an e-mail, make sure you get to the point in the first few sentences. I’m only going to look at what I see in the window in outlook and won’t open it.
- Think ahead about what I’m going to say.
- Layout my key points and why to listen to the rest of the message (or read the entire e-mail)
- Just provide enough information to justify a call or meeting
What Will Happen With Generic Lipitor (atorvastatin)?
Well, it finally looks like generic Lipitor will be on the market soon. I think November 30th is still the date.
Of course, now the question is what will this mean to you (the consumer)? Since atorvastatin will be distributed by only one manufacturer for the first six months after the patent expires, there will not be a significant price drop. Therefore, I know at least one (and have heard two) PBMs will be blocking the generic drug during that time. Consumers will be able to get Lipitor at a generic copay.
I’ve offered my opinion on scenarios like this before. I think it’s confusing to the consumer. It’s great for Pfizer and generally everyone wins since it’s the same out-of-pocket costs to the consumer and lower cost to the plan sponsor (employer) than the exclusive generic (due to rebates), BUT I think it sends a confusing message. “You can and should use generics except for in some cases where the brand drug is cheaper.” I’m not sure how this plays out in states where generic substitution is required by law.
Of course, your other option is to go use the Lipitor $4 coupon. If I were the Pfizer brand manager for Lipitor, I would offer a $50 payment for a 1-year supply of Lipitor and lock people in for the year. [A seperate discussion needs to be had about how cash and coupon claims which don't necessarily get adjudicated affect adherence measures for bonus payments like Star Ratings...and yes, I know that coupons aren't supposed to be used for Medicare members, but I don't think that's monitored well.]
So, you might go to get your generic Lipitor and leave with the brand at your generic copay. On the other hand, I wouldn’t be surprised to see some PBM negotiate well enough to get a better price on the generic than Lipitor (net of rebate). [Of course, these are the types of scenarios that cause friction in the supply chain. Which drug can the retailer buy better? Does the client get the rebates shared with them or not?]
I know this is what some companies like GoodRx are looking at with their application which compares drug prices across retailers. It shows you if there’s a coupon available (see broader article on them). It suggests savings like splitting the pill. (No mail or 90-day promotion yet that I saw.) Of course, this is from a cash paying customer perspective. But, with atorvastatin, you may want to compare your plan design with the cash price with coupons. You’ll want to know if it’s part of the $4 generics program or if you get a better price with the CVS or Walgreens discount card programs.
Here’s two examples from GoodRx. One is for Lipitor which shows some variation (and has no generic today). The other is for Prozac which has been available as a generic for a while.
Touch and Body Language in the Physician Encounter
I was watching this TED video the other day from a physician and writer Abraham Verghese. It was interesting since his whole point was about the ability to relate to your patient through human touch and the power that has on the patient’s trust and experience. As we move towards move EMRs and other technologies, we have to make sure we don’t over-engineer the patient experience.
I was reminded of this again when reading KevinMD’s blog where there was a post on using body language. How many of us think about what our body language is saying?
Or do we think about our clothing selection? While the white coat may create trust, does the tie create a sense of being aloof? Or should you consider different color sections to seem more approachable?
Food for thought.


November 30, 2011




















